Selective serotonin reuptake inhibitors enhance cancer immunosurveillance by pleiotropic mechanisms.
Saved in:
| Title: | Selective serotonin reuptake inhibitors enhance cancer immunosurveillance by pleiotropic mechanisms. |
|---|---|
| Authors: | Alvarez-Valadez K; Team Metabolism, Cancer & Immunity, Centre de Recherche des Cordeliers, INSERM UMRS1138, Sorbonne Université, Université de Paris Cité, Institut Universitaire de France, Paris, France., Kroemer G; Team Metabolism, Cancer & Immunity, Centre de Recherche des Cordeliers, INSERM UMRS1138, Sorbonne Université, Université de Paris Cité, Institut Universitaire de France, Paris, France.; INSERM US23/CNRS UAR 3655, Metabolomics and Cell Biology Platforms, Institut Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Department of Biology, Institut du Cancer Paris CARPEM, Hôpital Européen Georges Pompidou, AP-HP, Paris, France., Djavaheri-Mergny M; Team Metabolism, Cancer & Immunity, Centre de Recherche des Cordeliers, INSERM UMRS1138, Sorbonne Université, Université de Paris Cité, Institut Universitaire de France, Paris, France. |
| Source: | Oncoimmunology [Oncoimmunology] 2025 Dec 31; Vol. 14 (1), pp. 2564734. Date of Electronic Publication: 2025 Sep 30. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2162-402X |
|---|---|
| DOI: | 10.1080/2162402X.2025.2564734 |
